Dinoterb

Dinoterb

SCHEMBL29487271

CC(C)(C)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O

nearest known ligand 0.79

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.79
MEN1 O00255 3/20 0.79
HTT P42858 3/20 0.79
SMN1; SMN2 Q16637 2/20 0.79
GALR3 O60755 1/20 0.79
L3MBTL1 Q9Y468 1/20 0.79
GPR35 Q9HC97 9/20 0.61
ALDH1A1 P00352 4/20 0.61
HPGD P15428 2/20 0.59
MAPK1 P28482 2/20 0.59
MAPT P10636 2/20 0.59
KDM4E B2RXH2 1/20 0.59
TTR P02766 1/20 0.59
CYP1A2 P05177 1/20 0.59
CYP2C9 P11712 1/20 0.59
ALOX15 P16050 1/20 0.59
ALOX12 P18054 1/20 0.59
RECQL P46063 1/20 0.59
PMP22 Q01453 1/20 0.59
HIF1A Q16665 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dinoterb SCHEMBL8535102 1.00 KMT2A (0.79) KMT2AMEN1HTTSMN1; SMN2GALR3
Dinoterb SCHEMBL53794 1.00 KMT2A (0.79) KMT2AMEN1HTTSMN1; SMN2GALR3
Dinoterb SCHEMBL424259 0.98 KMT2A (0.77) KMT2AMEN1HTTSMN1; SMN2GALR3
Dinoterb SCHEMBL11379609 0.94 KMT2A (0.70) KMT2AMEN1HTTSMN1; SMN2GALR3
Dinoterb SCHEMBL9006380 0.92 GPR35 (0.76) KMT2AMEN1HTTSMN1; SMN2GALR3
SCHEMBL3236587 0.89 MEN1 (1.00) KMT2AMEN1HTTSMN1; SMN2GALR3
Dinoterb SCHEMBL4658673 0.84 MEN1 (0.56) KMT2AMEN1HTTSMN1; SMN2GALR3
Dinoterb SCHEMBL9706953 0.84 MEN1 (0.56) KMT2AMEN1HTTSMN1; SMN2GALR3
SCHEMBL19130787 0.84 MEN1 (0.82) KMT2AMEN1HTTSMN1; SMN2GALR3
SCHEMBL397532 0.82 GPR35 (0.62) KMT2AMEN1HTTSMN1; SMN2GALR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4483376-A1 MEASUREMENT, DIAGNOSIS, TREATMENT AND MANAGEMENT OF METABOLIC SYNDROME García Sada, Fernando (MX) 2025-01-01 EP claimed
CN-118922890-A Measurement, diagnosis, treatment and management of metabolic syndrome 费尔南多·加西亚·萨达 2024-11-08 CN claimed
WO-2023161832-A1 MEASUREMENT, DIAGNOSIS, TREATMENT AND MANAGEMENT OF METABOLIC SYNDROME GARCIA SADA FERNANDO (MX) 2023-08-31 WO claimed
EP-4055132-A1 PROCESS OF REDUCING MALODORS ON FABRICS The Procter & Gamble Company (US) 2022-09-14 EP claimed
CN-114630888-A Method for reducing malodor on fabrics 宝洁公司 2022-06-14 CN claimed
WO-2025108865-A1 HERBICIDAL COMPOSITIONS BAYER AKTIENGESELLSCHAFT (DE) 2025-05-30 WO disclosed
EP-4483376-A1 MEASUREMENT, DIAGNOSIS, TREATMENT AND MANAGEMENT OF METABOLIC SYNDROME García Sada, Fernando (MX) 2025-01-01 EP disclosed
CN-118922890-A Measurement, diagnosis, treatment and management of metabolic syndrome 费尔南多·加西亚·萨达 2024-11-08 CN disclosed
WO-2023161832-A1 MEASUREMENT, DIAGNOSIS, TREATMENT AND MANAGEMENT OF METABOLIC SYNDROME GARCIA SADA FERNANDO (MX) 2023-08-31 WO disclosed
EP-4205142-A1 SYSTEMS AND METHODS FOR MEASURING, LEARNING, AND USING EMERGENT PROPERTIES OF COMPLEX ADAPTIVE SYSTEMS EMERJA CORPORATION (US) 2023-07-05 EP disclosed
CN-116250044-A Systems and methods for measuring, learning, and using emerging properties of complex adaptive systems 埃梅里亚公司 2023-06-09 CN disclosed
EP-4055132-A1 PROCESS OF REDUCING MALODORS ON FABRICS The Procter & Gamble Company (US) 2022-09-14 EP disclosed
CN-114630888-A Method for reducing malodor on fabrics 宝洁公司 2022-06-14 CN disclosed
WO-2022047228-A1 SYSTEMS AND METHODS FOR MEASURING, LEARNING, AND USING EMERGENT PROPERTIES OF COMPLEX ADAPTIVE SYSTEMS EMERJA CORPORATION (US) 2022-03-03 WO disclosed